RS

Ritesh Srivastava

Director Director DIN 01008307
DIN 01008307 First appointment Feb 2007 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Ritesh Srivastava

Data last updated:

Ritesh Srivastava was a Director at Rochwell Pharma Private Limited (2007–2008) and Director at Masonic Pharmaceuticals Private Limited (from 2007). The companies operate in Chemicals.

DIN 01008307
Primary Designation Director
Industry Chemicals
First Appointment 06 Feb 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rochwell Pharma Private Limited U24233DL2007PTC158910
Director06 Feb 20072007Strike Off
Director06 Aug 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Masonic Pharmaceuticals Private Limited
Rochwell Pharma Private Limited
Premium access

Shareholding and investment profile for Ritesh Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Srivastava

Ritesh Srivastava was first appointed on 06 Feb 2007 as Director at Rochwell Pharma Private Limited.

Ritesh Srivastava held 2 earlier board appointments: Rochwell Pharma Private Limited (Director, 06 Feb 2007 to 12 Aug 2008); Masonic Pharmaceuticals Private Limited (Director, from 06 Aug 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available